Showing 1 - 5 results of 5 for search 'Maria Betina Pampena', query time: 0.05s Refine Results
  1. 1
    Phenotypic Characterization of SLex+ and CLA+ CD4+ T Cells

    Phenotypic Characterization of SLex+ and CLA+ CD4+ T Cells by Leticia Kuri-Cervantes, Maria Betina Pampena, Michael R. Betts

    Published 2020-12-01
    Get full text
    Article
  2. 2
    Avelumab, an IgG1 anti-PD-L1 Immune Checkpoint Inhibitor, Triggers NK Cell-Mediated Cytotoxicity and Cytokine Production Against Triple Negative Breast Cancer Cells

    Avelumab, an IgG1 anti-PD-L1 Immune Checkpoint Inhibitor, Triggers NK Cell-Mediated Cytotoxicity and Cytokine Production Against Triple Negative Breast Cancer Cells by Estefanía Paula Juliá, Analía Amante, María Betina Pampena, José Mordoh, José Mordoh, José Mordoh, Estrella Mariel Levy

    Published 2018-09-01
    Get full text
    Article
  3. 3
    Changes in the TCRβ Repertoire and Tumor Immune Signature From a Cutaneous Melanoma Patient Immunized With the CSF-470 Vaccine: A Case Report

    Changes in the TCRβ Repertoire and Tumor Immune Signature From a Cutaneous Melanoma Patient Immunized With the CSF-470 Vaccine: A Case Report by Mariana Aris, Alicia Inés Bravo, María Betina Pampena, Paula Alejandra Blanco, Ibel Carri, Daniel Koile, Patricio Yankilevich, Estrella Mariel Levy, María Marcela Barrio, José Mordoh, José Mordoh, José Mordoh

    Published 2018-05-01
    Get full text
    Article
  4. 4
    Phenotypic and functional dysregulated blood NK cells in Colorectal cancer patients can be activated by cetuximab plus IL-2 or IL-15.

    Phenotypic and functional dysregulated blood NK cells in Colorectal cancer patients can be activated by cetuximab plus IL-2 or IL-15. by Yamila Sol Rocca, María Paula Roberti, Estefanía Paula Juliá, María Betina Pampena, Luisina Bruno, Sergio Rivero, Eduardo Huertas, Fernando Sánchez Loria, Alejandro Pairola, Anne Caignard, José Mordoh, José Mordoh, José Mordoh, Estrella Mariel Levy

    Published 2016-10-01
    Get full text
    Article
  5. 5
    Phase II Study of Adjuvant Immunotherapy with the CSF-470 Vaccine Plus Bacillus Calmette–Guerin Plus Recombinant Human Granulocyte Macrophage-Colony Stimulating Factor vs Medium-Dose Interferon Alpha 2B in Stages IIB, IIC, and III Cutaneous Melanoma Patients: A Single Institution, Randomized Study

    Phase II Study of Adjuvant Immunotherapy with the CSF-470 Vaccine Plus Bacillus Calmette–Guerin Plus Recombinant Human Granulocyte Macrophage-Colony Stimulating Factor vs Medium-Do... by José Mordoh, José Mordoh, José Mordoh, María Betina Pampena, Mariana Aris, Paula Alejandra Blanco, Mónica Lombardo, Erika María von Euw, Soledad Mac Keon, Michelle Yépez Crow, Alicia Inés Bravo, Juan Manuel O’Connor, Ana Gabriela Orlando, Ana Gabriela Orlando, Franco Ramello, Estrella Mariel Levy, María Marcela Barrio

    Published 2017-05-01
    Get full text
    Article

Search Tools: